High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Mitacs (IT15089)
This publication has 75 references indexed in Scilit:
- SOCS3 Expression Correlates with Severity of Inflammation, Expression of Proinflammatory Cytokines, and Activation of STAT3 and p38 MAPK in LPS-Induced InflammationIn VivoMediators of Inflammation, 2013
- FXR ligands protect against hepatocellular inflammation via SOCS3 inductionCellular Signalling, 2012
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial CellsJournal of Biological Chemistry, 2010
- Cannabinoids as Novel Anti-Inflammatory DrugsFuture Medicinal Chemistry, 2009
- Post-transcriptional control of cytokine productionNature Immunology, 2008
- Cannabinoid-based drugs as anti-inflammatory therapeuticsNature Reviews Immunology, 2005
- Regulation of TNF‐α and IFN‐γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary diseaseThe FASEB Journal, 2003
- Many actions of cyclooxygenase‐2 in cellular dynamics and in cancerJournal of Cellular Physiology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001